Howe & Rusling’s Bio-Techne TECH Stock Holding History

Howe & Rusling’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32	Closed	-$2K	–	954
2022 Q3	$2K	Hold	32	–	–	﹤0.01%	912
2022 Q2	$3K	Buy	32 +4	+14%	+$375	﹤0.01%	824
2022 Q1	$3K	Hold	28	–	–	﹤0.01%	809
2021 Q4	$4K	Hold	28	–	–	﹤0.01%	760
2021 Q3	$3K	Hold	28	–	–	﹤0.01%	807
2021 Q2	$3K	Sell	28 -8	-22%	-$842	﹤0.01%	765
2021 Q1	$3K	Sell	36 -16	-31%	-$1.46K	﹤0.01%	764
2020 Q4	$4K	Hold	52	–	–	﹤0.01%	685
2020 Q3	$3K	Hold	52	–	–	﹤0.01%	661
2020 Q2	$3K	Buy	+52	New	+$3.11K	﹤0.01%	633
2014 Q2	–	Sell	-1,204	Closed	-$26K	–	922
2014 Q1	$26K	Buy	+1,204	New	+$27.1K	0.01%	419
2013 Q4	–	Sell	-1,300	Closed	-$26K	–	880
2013 Q3	$26K	Hold	1,300	–	–	0.01%	432
2013 Q2	$22K	Buy	+1,300	New	+$21.6K	0.01%	474

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Howe & Rusling's TECH Position: Q4 2022 in Review

Howe & Rusling sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 32 shares — an estimated $2K sold.

Howe & Rusling first reported a position in TECH in Q2 2013 and held it in 13 quarters. The position peaked at $26K in Q1 2014. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Howe & Rusling reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Howe & Rusling sold 32 Bio-Techne shares in Q4 2022, an estimated $2K.
Howe & Rusling first reported a position in Bio-Techne in Q2 2013 and held it in 13 quarters.
Howe & Rusling's Bio-Techne position peaked at $26K in Q1 2014.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.